🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Glad to be awarded with our co-fellows! Grateful for continuous support from our Roswell Park Hematology/Oncology Fellowship fellowship program.

Excited to be in Chicago for #AACR2025! Great catching up with mentors and meeting new people. Stop by my poster tomorrow — #2039 (Section 31-8)! If you see me around, feel free to say hi!

Ready for big news at #AACR25? 👏 Dr. Prantesh Jain MD, FACP, MD, FACP, will present initial findings from a multicenter phase 1 trial of JNJ-86974680 at the AACR Annual Meeting! 🔗Learn More: roswellpark.org/newsroom/20250…

Congratulations to this year’s class of Conquer Cancer grant and award recipients! Are you one of them? Tell us in the comments! We can't wait to celebrate with you at #ASCO25. Full list of recipients: brnw.ch/21wSR0A ASCO

Honored to represent UNC Hematology-Oncology Fellowship alongside my cofellow in the FDA-AACR Educational Fellowship. Our mock ODAC panel tackled tough regulatory and trial design debates. I’m a better oncologist today. Grateful to be part of this amazing group! AACR FDA UNC Lineberger

Was nice to work with amazing co-fellows from various institutions and learn the drug regulatory processes from people FDA Oncology leading this field on this one year curriculum supported by AACR Highly recommended for fellows interested in drug development Roswell Park Hematology/Oncology Fellowship

We are looking for an associate research scientist and lab manager for our translational cancer immunology lab at Yale. Please email ([email protected]) or DM me to apply. Full information about the job and the requirements can be found here: jobrxiv.org/job/yale-schoo… Pls RT!

A tribute to Dr. Agatsuma was a meaningful moment during my DESTINY-Gastric04 presentation at #ASCO25 with NEJM publication. I deeply respect him and the entire team behind the development of T-DXd. ASCO OncoAlert Daiichi Sankyo Daiichi Sankyo US AstraZeneca Oncology at AstraZeneca

The best session thus far at #ASCO25 Followed by NeoAvAx updates, insightful transcriptome analysis of IMmotion010 by Sumanta K. Pal, MD, FASCO, ML-based multi asset analysis including ECM using the 9ER cohort by David Braun, and MadCAM-1 prognostic role in RCC by a rising star Renee Maria Saliby!

My friend/previous senior resident Hirotaka Miyashita, MD from Mount Sinai Beth Israel Internal Medicine currently a fellow at Dartmouth Cancer Center delivered an elegant (as always) presentation of his work investigating the impact of NK- cell hot vs cold status on ICB efficacy Razelle Kurzrock, MD

It is really such a pleasure and honor to mentor such incredibly talented young investigators.

Really glad to meet Soki Kashima from David Braun Yale Cancer Center lab at #ASCO25 Very impressive work utilizing humongous scRNAseq, TCR/BCRseq data to capture the characteristics of myeloid components in mRCC response/resistance to IO-based therapy. #JapanesephysicianscientistsinUS

Most importantly, I was able to re-confirm the tight and really cool connections among co-fellows at Roswell Park Hematology/Oncology Fellowship! We from “Snow City” walked around the conference site, talked about science, foods, work, and life in the Windy City! It’s always best to have good colleagues…!

It’s a privilege to work with colleagues who are immensely motivated, breaking barriers, and yet continues to be humble. Proud to call them friends. Roswell Park Hematology/Oncology Fellowship Hem-Onc Fellows Network IMG Oncologists #ASCO2025